Medicine
fromwww.theguardian.com
3 days agoNovo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer
Novo Nordisk launched a $9bn unsolicited bid to acquire Metsera, directly challenging Pfizer's existing takeover offer amid competition for obesity-drug assets.